|
1
|
Muntañola A, Mirás F, Hernández‐Rivas JA, Baile M, Osorio S, Terol MJ, Gimeno E, Alonso R, Baltasar P, López‐García A, Labrador J, López‐Jiménez J, Hernández‐Rodríguez I, Alfayate A, Oliveira AC, Gómez‐Roncero MI, Vidal MJ, Bárez A, López‐Rubio M, Riaza R, Correa J, Hernández‐Sánchez E, Romero P, Yáñez L, Andreu R, Santiago R, Zabalza A, Torres A, Seri C, Ramírez‐Payer A, García‐Malo MD, García‐Pintos M, Mateos Mazón JJ, Rodríguez‐Fernández A, Ma Vale A, Ríos E, Loscertales J, Do Nascimiento J, Pérez‐Fernández I, José Lis M, Pérez S, Ruiz ME, Villalón L, Velasquez CA, Campoy F, Muiña B, Soler JA, Sánchez MJ, Cuesta A, Pimentel A, Sánchez‐Ramírez M, Ruiz‐Camps I, Villacampa G, Bosch F, Abrisqueta P. IMPACT OF DISEASE TREATMENT ON THE OUTCOME OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITH COVID‐19: A MULTICENTER STUDY ON BEHALF OF GELLC. Hematol Oncol 2021. [PMCID: PMC8426866 DOI: 10.1002/hon.53_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|